Advances in rehabilitation medicine

Ng, Yee Sien; Chew, Effie; Samuel, Geoffrey Sithamparapillai; Tan, Yeow Leng; Kong, Keng He

doi:10.11622/smedj.2013197

Cited by 9 publications

(16 citation statements)

References 134 publications

(325 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It does so through producing high-intensity, active, repetitive and task-oriented movements, utilising the principles of motor learning. (8) A 2011 Cochrane article on the use of VR-based therapy in stroke recovery, which reviewed 19 randomised controlled trials (with a total of 565 poststroke participants), concluded that there was some evidence that VR-based therapy was more effective than conventional interventions and achieved better arm function.…”

Section: Discussionmentioning

confidence: 99%

The use of virtual reality-based therapy to augment poststroke upper limb recovery

Samuel¹,

Choo²,

Chan³

et al. 2015

smedj

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

The use of virtual reality-based therapy to augment poststroke upper limb recovery

Samuel¹,

Choo²,

Chan³

et al. 2015

smedj

Self Cite

View full text Add to dashboard Cite

“…According to the review by Ng et al, 2013 [18], the frailty requires a new approach based on the following reasons. Firstly, frailty is interconnected but may occur irrespective of any comorbidity or inability [19, 20].…”

mentioning

confidence: 99%

“…Secondly, frailty is associated with a greater risk of hospital readmission, admission to a care home, a worse outcome following surgery, post-operative complications and a greater risk of falling, dementia, general morbidity and mortality. Thirdly, it is potentially reversible as a result of specific intervention such as rehabilitation and exercise [18]. …”

mentioning

confidence: 99%

Is Technology Present in Frailty? Technology a Back-up Tool for Dealing with Frailty in the Elderly: A Systematic Review

Mugueta-Aguinaga

Garcia‐Zapirain

2017

Aging and disease

View full text Add to dashboard Cite

This study analyzes the technologies used in dealing with frailty within the following areas: prevention, care, diagnosis and treatment. The aim of this paper is, on the one hand, to analyze the extent to which technology is present in terms of its relationship with frailty and what technological resources are used to treat it. Its other purpose is to define new challenges and contributions made by physiotherapy using technology. Eighty documents related to research, validation and/or the ascertaining of different types of hardware, software or both were reviewed in prominent areas. The authors used the following scales: in the area of diagnosis, Fried’s phenotype model of frailty and a model based on trials for the design of devices. The technologies developed that are based on these models accounted for 55% and 45% of cases respectively. In the area of prevention, the results proved similar regarding the use of wireless sensors with cameras (35.71%), and Kinect™ sensors (28.57%) to analyze movements and postures that indicate a risk of falling. In the area of care, results were found referring to the use of different motion, physiological and environmental wireless sensors (46,15%), i.e. so-called smart homes. In the area of treatment, the results show with a percentage of 37.5% that the Nintendo® Wii™ console is the most used tool for treating frailty in elderly persons. Further work needs to be carried out to reduce the gap existing between technology, frail elderly persons, healthcare professionals and carers to bring together the different views about technology. This need raises the challenge of developing and implementing technology in physiotherapy via serious games that may via play and connectivity help to improve the functional capacity, general health and quality of life of frail individuals.

show abstract

“…14 The introduction of BoNT-A has had a significant impact on the treatment of focal spasticity in the upper limbs, and it is widely viewed as a welltolerated and efficacious treatment option (when used appropriately, based on the relevant country-specific guidance and applicable summary of product characteristics) in conjunction with physical therapy programmes. 25,[34][35][36][37][38] Preliminary studies suggest that it is best delivered early, when spastic paresis first sets in, in order to minimise the development of secondary complications, such as contractures. 39 It is important to note that patients must also exercise and receive physical and occupational therapy, as long-term disuse can induce muscle atrophy.…”

Section: Treatment Optionsmentioning

confidence: 99%

“…However, many patients contend with insufficient outpatient rehabilitation and monitoring in the long term ( Table 5). 8 Although physical therapy (stretching, positioning and splints) remains the mainstay of the management of spastic paresis, 36 the goals of physical therapy are often not well defined, leading to patients feeling unmotivated and disheartened, which may mean they decide to discontinue their rehabilitation. Variations in treatment frequency or reliance on multiple therapists can also affect the patient's confidence in the therapy and their perception of its usefulness.…”

Section: Patient Factorsmentioning

confidence: 99%

Spastic Paresis and Rehabilitation – The Patient Journey

Bowers¹,

Fheodoroff²,

Khan³

et al. 2016

European Neurological Review

View full text Add to dashboard Cite

S pastic paresis is a complex condition associated with damage to the upper motor neurons, typically caused by cerebral palsy, multiple sclerosis, stroke or trauma. Despite substantial impact on patients' independence and burden on caregivers, there is a lack of consensus on optimal management of this condition and the patient journey remains unclear. A group of physicians, experienced in spasticity management, recently convened with the objective of analysing the patient journey from a care pathway perspective in different geographical regions and under different conditions from acute phase to long-term/chronic disease status. The experts reviewed results from recent patient and healthcare practitioner surveys on the subject and assessed how current patient pathways could be improved, using their own experiences to highlight the issues related to management deficiencies in their individual countries. The group divided the patient journey into steps, considering the evidence from the point of view of healthcare practitioners, patients, caregivers and funders/payors. This paper is a response to the lack of consensus on the optimal management of spastic paresis, and acts as a call to action to develop a consistent care pathway that could be applied across a broad range of illnesses, using an interdisciplinary approach. KeywordsSpastic paresis, patient rehabilitation, patient journey, patient care, care pathway Disclosure: David Bowers has participated in an advisory board for Ipsen and has been a trainer for Allergan and Medtronic. Klemens Fheodoroff has received unrestricted research grants from Ipsen and Merz, and honoraria for instructional courses from Ipsen, Allergan and Merz. Patricia Khan has participated in advisory boards for Ipsen, and has received honoraria for instructional courses from Ipsen and Allergan. Julian P Harriss has received research funding into current practice in spasticity management (the SPACE study, supported by Merz Pharma) and expenses for participation in expert panels (Ipsen). Khashayar Dashtipour has received compensation/honoraria for services as a consultant or an advisory committee member or speaker from Allergan, Inc., Ipsen Biopharmaceuticals, Inc., Lundbeck Inc., Merz Pharmaceuticals, Teva Pharmaceutical Industries Ltd., UCB Inc., Impax Pharmaceutical and US World Meds. Laxman Bahroo has received personal compensation from Teva Neuroscience, UCB pharma, Impax, Allergan, Ipsen, US World Meds, AbbVie, Lundbeck and Acadia for consulting, serving on a scienti c advisory board or speaking activities, and research support from Ipsen and Teva Neuroscience. Michael Lee has participated in an advisory board for Ipsen. Denis Zakharov has received personal compensation from Ipsen and Merz for consulting, serving on a scienti c advisory board or speaking activities. Jovita Balcaitiene is an employee of Ipsen Pharma. Virgilio Evidente has received research support from Ipsen and honoraria for consulting and/or speaking from Ipsen, Merz, Solstice, US WorldMeds, Lundbeck, UCB, Xenoport, Te...

show abstract

Advances in rehabilitation medicine

Cited by 9 publications

References 134 publications

The use of virtual reality-based therapy to augment poststroke upper limb recovery

The use of virtual reality-based therapy to augment poststroke upper limb recovery

Is Technology Present in Frailty? Technology a Back-up Tool for Dealing with Frailty in the Elderly: A Systematic Review

Spastic Paresis and Rehabilitation – The Patient Journey

Contact Info

Product

Resources

About